Become a member of BioTechniques (it's free!) and receive the latest news in the life sciences and member-exclusives.

Michael Fiebig on the use of nanobodies against SARS-CoV-2

Written by The Nanomed Zone, Michael Fiebig (Absolute Antibody, Redcar, UK)
Interviews Nanomedicine

As an expert in the field, Michael Fiebig of Absolute Antibody (Redcar, UK) speaks about the latest developments in synthetic nanobodies – sybodies – for use as neutralizing agents against the SARS-CoV-2 virus.   Can you please give a short background of the work conducted and the aims of Absolute Antibody Ltd? Absolute Antibody is an antibody producer/supplier and CRO specializing in the sequencing, engineering and recombinant expression of antibodies. We were founded with the vision that everyone should have access to recombinant and engineered antibodies, not just researchers in the biopharmaceutical space, but also researchers in academia and diagnostic...

To view this content, please register now for access

Join our member community for FREE to access a collection of journal and online-only features, including:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news and journal updates delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!